glioblastoma multiforme

ashkan zandi department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, iran taraneh moini zanjani department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, iran seyed ali ziai department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, iran yalda khazaei poul department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, iran mostafa haji molla hoseini department of immunology, school of medicine, shahid beheshti university of medical sciences, tehran, iran

background: combination therapy has generated remarkable motivation in the clinical setting since it boosts the therapeutic potential of anticancer drugs. glioblastoma multiforme (gbm) is the most common and aggressive malignant brain tumor which affects patients in all ages, and being principally resistant to treatment. methods: in this study, temozolomide as a standard chemotherapeutic drug f...

متن کامل

Activity of bortezomib in glioblastoma.

Journal: :Anticancer research 2006

Jan Styczynski Dorota Olszewska-Slonina Beata Kolodziej Malgorzata Napieraj Mariusz Wysocki

BACKGROUND Chemotherapy is the commonly accepted standard therapy for most types of brain tumor, especially in medulloblastoma, primitive neuroectodermal tumor and astrocytoma. However, no efficient therapy has been established to date for glioblastoma multiforme. The aim of the present study was to analyze the activity of bortezomib in glioblastoma cell lines in comparison with that in a pedia...

متن کامل

Prion Protein in Glioblastoma Multiforme

Journal: :International Journal of Molecular Sciences 2019

متن کامل

Drop metastasis in glioblastoma multiforme

Journal: :Indian Journal of Medical and Paediatric Oncology 2020

متن کامل

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید